QOL and Sarcopenia in Patients With Ascites
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study ID
- NCT05726747
- Status
- Recruiting
Conditions
- Ascites Hepatic
- Ascites, Malignant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Quality of Life surveys — DIAGNOSTIC_TESTQoL and sarcopenia assessments
Study Details
Clinical data regarding quality of life in patients with refractory ascites is limited and preceded the development of newer questionnaires that may be more robust. One primary objective of this study is to study changes in quality in life in a prospective fashion using newer general and ascites-specific quality of life survey instruments specific to benign and malignant etiologies. Sarcopenia is a condition that is prevalent in cancer and cirrhosis. Current data is retrospective and associative, evaluating heterogeneous patient populations at different stages within the timeline of refractory ascites. The other primary objective of this study is to study sarcopenia in a prospective fashion and to understand its kinetics once a patient develops refractory ascites. Prospectively-obtained measures of deterioration in patient-reported outcomes and in muscle mass will form the basis for the next stage of investigation of interventions to mitigate these declines.
Key Dates
- Start date
- May 23, 2023
- Status verified
- Aug 2025
- Primary completion
- Apr 30, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 70 participants (estimated)
Primary Outcome Measure
Health-Related Quality of Life scores as measured by the PROMIS-10 questionnaire [ Time Frame: 6 months ]
Central Contacts
- Michael C Soulen, MD2154218647
- Kathleen Thomas, MS215-746-0352
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania Perelman School of Medicine | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
Related Studies
- Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver CirrhoticsPHASE1 · Recruiting · PharmaIN · Chandler, Arizona
- Albumin Assisted Diuresis in Patients with Cirrhosis and AscitesPHASE2 · Recruiting · Anahita Rabiee MD MHS · West Haven, Connecticut